Pankhuri Wanjari
Overview
Explore the profile of Pankhuri Wanjari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao X, Schmidt A, Zhang D, Li P, Wang X, Ko H, et al.
Mod Pathol
. 2024 Jul;
37(10):100566.
PMID: 39025404
The pathogenesis of neuroendocrine carcinomas (NECs) and mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) in the gastrointestinal tract remains poorly understood. This study aims to characterize the clinicopathologic and molecular features of NEC/MiNEN...
2.
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Kaur A, Rojek A, Symes E, Nawas M, Patel A, Patel J, et al.
Blood Cancer J
. 2024 Jun;
14(1):99.
PMID: 38890297
Current therapies for high-grade TP53-mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell transplantation in the minority who achieve a complete response to...
3.
Higgins K, Sadow P, Johnson D, Wang P, Wanjari P, Cipriani N
Head Neck Pathol
. 2024 May;
18(1):39.
PMID: 38727854
Background: Columnar cell papillary thyroid carcinoma (CC-PTC) is a morphologic subtype of papillary thyroid carcinoma with a variable prognosis. It is characterized by neoplastic thyroid follicular-derived cells with pseudostratified columnar...
4.
Devins K, Ordulu Z, Mendoza R, Croce S, Haridas R, Wanjari P, et al.
Am J Surg Pathol
. 2024 Apr;
48(7):813-824.
PMID: 38630911
Uterine inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal neoplasms of uncertain malignant potential. Aside from the recently described risk stratification score, which has not been validated by other studies, and...
5.
Mendoza R, Chen-Yost H, Wanjari P, Wang P, Symes E, Johnson D, et al.
Cancer Med
. 2024 Jan;
13(1):e6873.
PMID: 38164123
Background: TP53 mutation is present in about 50.8% of lung adenocarcinomas, frequently in combination with other genetic alterations. However, a rare subset harbors the TP53 mutation alone. Methods: Next-generation sequencing...
6.
Saygin C, Zhang P, Stauber J, Aldoss I, Sperling A, Weeks L, et al.
Blood Cancer Discov
. 2023 Dec;
5(3):164-179.
PMID: 38150184
Significance: CH is a precursor lesion for lymphoblastic leukemogenesis. ALL with MyM has distinct genetic and clinical characteristics, associated with adverse survival outcomes after chemotherapy. CH can precede ALL years...
7.
Kraft I, Basdag H, Koppayi A, Rodgers C, Saygin C, Haribabu Y, et al.
Genet Med
. 2023 Dec;
26(3):101037.
PMID: 38054407
Purpose: To identify likely germline DNA variants from sequential tumor profiling data from hematopoietic malignancies (HMs). Methods: The coefficient of variance was calculated from variant allele frequency of next-generation sequencing...
8.
Johnston H, Rahmani Youshanlouei H, Osei C, Patel A, Duvall A, Wang P, et al.
Blood Adv
. 2023 Dec;
8(1):164-171.
PMID: 38039510
Various socioeconomic and biologic factors affect cancer health disparities and differences in health outcomes. To better characterize the socioeconomic vs biologic determinants of acute lymphoblastic leukemia (ALL) outcomes, we conducted...
9.
Mendoza R, Wang P, Smith H, Fitzpatrick C, Haridas R, Wanjari P, et al.
Am J Surg Pathol
. 2023 Oct;
47(12):1398-1408.
PMID: 37796179
Ovarian steroid and Leydig cell tumors (SCT and LCT, respectively) are rare stromal tumors, with aggressive behavior described in approximately one third of SCTs. Previously reported features potentially predictive of...
10.
Doytcheva K, Gallan A, Wang P, Wanjari P, Segal J, Antic T
Hum Pathol
. 2023 Mar;
136:25-33.
PMID: 36997032
Presented are four cystic renal masses which harbored a MED15::TFE3 gene fusion detected by RNAseq, mimicking multilocular cystic neoplasm of low malignant potential. Clinicopathologic and outcomes data were collected for...